2m 2m 2m 2m 2m 2m 2m
INOVIO PHARMA (INO)
NASDAQ
$1.14+$0.01 (+0.88%)
Price as of Jun 24, 2026 4:45 AM EDT- $93.0MMarket Cap
- -45.15%1-Year Change
- BiotechnologyIndustry
INOVIO PHARMA (INO)
$1.14+$0.01 (+0.88%)
INO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.13 | ||
Change | +$0.02 (+1.80%) | ||
Open | $1.09 | ||
High | $1.16 | ||
Low | $1.09 | ||
Previous Close | $1.11 | ||
Volume | 1,178,672 | ||
30-Day Average Volume | 1,509,752 | ||
1-Week Change | 1.80% | ||
1-Month Change | -16.30% | ||
1-Year Change | -45.15% | ||
3-Year Change | -78.26% | ||
5-Year Change | -98.92% | ||
Fundamentals | |||
Shares Outstanding | 82.3M | ||
Total Assets | $49.8M | ||
Market Cap | $93.0M | ||
Enterprise Value | $66.7M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$19.7M | ||
Free Cash Flow | -$21.6M | ||
EBIT | -$19.7M | ||
EBITDA | -$19.4M | ||
Net Working Capital | $1.5M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 15 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 01/25/2024 | ||
Earnings & Revenue